PubMed

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R.

Diabetes Care. 2004 May;27(5):1164-70.PMID: 15111539 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.

Diabetologia. 2008 Nov;51(11):2100-7. Epub 2008 Aug 22.PMID: 18719882 [PubMed - indexed for MEDLINE]Related articles

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH.

Diabetologia. 2005 Jan;48(1):149-55. Epub 2004 Dec 23.PMID: 15616804 [PubMed - indexed for MEDLINE]Related articles

Progression of nephropathy in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Lajer M, Ek J, Hansen T, Pedersen O, Parving HH.

Mol Genet Metab. 2008 Jul;94(3):347-51. Epub 2008 May 7.PMID: 18467141 [PubMed - indexed for MEDLINE]Related articles

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

Diabetes Care. 2006 Feb;29(2):334-9.PMID: 16443883 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.

Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.

J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. Epub 2008 Apr 16.PMID: 18413184 [PubMed - indexed for MEDLINE]Related articles

Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, Luttrell LM, Wilson PW; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Group.

J Clin Endocrinol Metab. 2008 May;93(5):1893-900. Epub 2008 Mar 4.PMID: 18319310 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Hovind P, Tarnow L, Oestergaard PB, Parving HH.

Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.

Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D.

Kidney Int. 2003 Aug;64(2):451-8.PMID: 12846740 [PubMed - indexed for MEDLINE]Related articles

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH.

Kidney Int. 2004 Sep;66(3):1180-6.PMID: 15327415 [PubMed - indexed for MEDLINE]Related articles

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.

Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, Tada H, Toyama T, Adachi H, Naito S, Oshima S, Nishida T, Kubota S, Takigawa M, Kurabayashi M.

Eur J Heart Fail. 2008 Apr;10(4):373-9. Epub 2008 Mar 11.PMID: 18337169 [PubMed - indexed for MEDLINE]Related articles

Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.

Araki S, Haneda M, Koya D, Sugimoto T, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

Diabetologia. 2007 Apr;50(4):867-73. Epub 2007 Jan 16.PMID: 17225121 [PubMed - indexed for MEDLINE]Related articles

Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG.

JAMA. 2006 Jul 26;296(4):421-6.PMID: 16868300 [PubMed - indexed for MEDLINE]Related articlesFree article